{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T18:56:14Z","timestamp":1725562574374},"publisher-location":"Berlin, Heidelberg","reference-count":102,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642141522"},{"type":"electronic","value":"9783642141539"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/400_2008_16","type":"book-chapter","created":{"date-parts":[[2009,5,6]],"date-time":"2009-05-06T13:42:47Z","timestamp":1241617367000},"page":"99-113","source":"Crossref","is-referenced-by-count":6,"title":["B Cells and Antibodies in MS"],"prefix":"10.1007","author":[{"given":"Markus","family":"Reindl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Kuenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,22]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/ni1100","volume":"5","author":"CD Allen","year":"2004","unstructured":"Allen CD et al (2004) Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 5:943\u2013952","journal-title":"Nat Immunol"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/35018581","volume":"406","author":"KM Ansel","year":"2000","unstructured":"Ansel KM et al (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309\u2013314","journal-title":"Nature"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1078\/0171-2985-00204","volume":"206","author":"S Arce","year":"2002","unstructured":"Arce S et al (2002)wThe role of long-lived plasma cells in autoimmunity. Immunobiology 206:558\u2013562","journal-title":"Immunobiology"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.21117","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61:288\u2013299","journal-title":"Ann Neurol"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ana.21363","volume":"63","author":"A Bar-Or","year":"2008","unstructured":"Bar-Or A et al (2008) Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol 63:395\u2013400","journal-title":"Ann Neurol"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.4049\/jimmunol.163.9.5133","volume":"163","author":"SE Baranzini","year":"1999","unstructured":"Baranzini SE et al (1999) B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol 163:5133\u20135144","journal-title":"J Immunol"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1056\/NEJMoa022328","volume":"349","author":"T Berger","year":"2003","unstructured":"Berger T et al (2003) Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 349:139\u2013145","journal-title":"N Engl J Med"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1126\/science.1076071","volume":"298","author":"NL Bernasconi","year":"2002","unstructured":"Bernasconi NL et al (2002) Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199\u20132202","journal-title":"Science"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1212\/WNL.42.9.1798","volume":"42","author":"PF Bray","year":"1992","unstructured":"Bray PF et al (1992) Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 42:1798\u20131804","journal-title":"Neurology"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ana.21311","volume":"63","author":"EC Breij","year":"2008","unstructured":"Breij EC et al (2008) Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 63:16\u201325","journal-title":"Ann Neurol"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1471-4159.1989.tb10930.x","volume":"52","author":"C Brunner","year":"1989","unstructured":"Brunner C et al (1989) Differential ultrastructural localization of myelin basic protein, myelin\/oligodendroglial glycoprotein, and 2\u2019\u00b4,3\u2019\u00b4-cyclic nucleotide 3\u2019\u00b4-phosphodiesterase in the CNS of adult rats. J Neurochem 52:296\u20132304","journal-title":"J Neurochem"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/brain\/124.11.2169","volume":"124","author":"S Cepok","year":"2001","unstructured":"Cepok S et al (2001) Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 124:2169\u20132176","journal-title":"Brain"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archneur.60.6.849","volume":"60","author":"S Cepok","year":"2003","unstructured":"Cepok S et al (2003) The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis. Arch Neurol 60:849\u2013855","journal-title":"Arch Neurol"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/awh486","volume":"128","author":"S Cepok","year":"2005","unstructured":"Cepok S et al (2005a) Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 128:1667\u20131676","journal-title":"Brain"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1172\/JCI200523661","volume":"115","author":"S Cepok","year":"2005","unstructured":"Cepok S et al (2005b) Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 115:1352\u20131360","journal-title":"J Clin Invest"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jneuroim.2006.06.031","volume":"180","author":"S Cepok","year":"2006","unstructured":"Cepok S et al (2006) Accumulation of class switched IgD-IgM- memory B cells in the cerebrospinal fluid during neuroinflammation. J Neuroimmunol 180:33\u201339","journal-title":"J Neuroimmunol"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ana.21195","volume":"62","author":"S Cepok","year":"2007","unstructured":"Cepok S et al (2007) Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection. Ann Neurol 62:458\u2013467","journal-title":"Ann Neurol"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.4049\/jimmunol.164.5.2782","volume":"164","author":"M Colombo","year":"2000","unstructured":"Colombo M et al (2000) Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol 164:2782\u20132789","journal-title":"J Immunol"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"11064","DOI":"10.1073\/pnas.0402455101","volume":"101","author":"A Corcione","year":"2004","unstructured":"Corcione A et al (2004) Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A 101:11064\u201311069","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","volume":"64","author":"BA Cree","year":"2005","unstructured":"Cree BA et al (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270\u20131272","journal-title":"Neurology"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneuroim.2006.06.029","volume":"180","author":"AH Cross","year":"2006","unstructured":"Cross AH et al (2006) Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 180:63\u201370","journal-title":"J Neuroimmunol"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.21240","volume":"63","author":"A Dal Bianco","year":"2008","unstructured":"Dal Bianco A et al (2008) Multiple sclerosis and Alzheimer\u2019s disease. Ann Neurol 63:174\u2013183","journal-title":"Ann Neurol"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","volume":"63","author":"GN DeLorenze","year":"2006","unstructured":"DeLorenze GN et al (2006) Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 63:839\u2013844","journal-title":"Arch Neurol"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/archneur.62.6.865","volume":"62","author":"MS Freedman","year":"2005","unstructured":"Freedman MS et al (2005) Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 62:865\u2013870","journal-title":"Arch Neurol"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1212\/01.WNL.0000147259.34163.33","volume":"63","author":"S Gaertner","year":"2004","unstructured":"Gaertner S et al (2004) Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis. Neurology 63:2381\u20132383","journal-title":"Neurology"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/5532","volume":"5","author":"CP Genain","year":"1999","unstructured":"Genain CP et al (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 5:170\u2013175","journal-title":"Nat Med"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1600-0404.2007.00872.x","volume":"116","author":"I Greeve","year":"2007","unstructured":"Greeve I et al (2007) Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort. Acta Neurol Scand 116:207\u2013210","journal-title":"Acta Neurol Scand"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/35876","volume":"391","author":"MD Gunn","year":"1998","unstructured":"Gunn MD et al (1998) A B-cell-homing chemokine made in lymphoid follicles activates Burkitt\u2019s lymphoma receptor-1. Nature 391:799\u2013803","journal-title":"Nature"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/rmv.503","volume":"16","author":"S Haahr","year":"2006","unstructured":"Haahr S, Hollsberg P (2006) Multiple sclerosis is linked to Epstein-Barr virus infection. Rev Med Virol 16:297\u2013310","journal-title":"Rev Med Virol"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/infdis\/161.6.1194","volume":"161","author":"K Hansen","year":"1990","unstructured":"Hansen K et al (1990) Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 161:1194\u20131202","journal-title":"J Infect Dis"},{"key":"16_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1056\/NEJMoa0706383","volume":"358","author":"SL Hauser","year":"2008","unstructured":"Hauser SL et al (2008) B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 358:676\u2013688","journal-title":"N Engl J Med"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1365-2249.2003.02114.x","volume":"132","author":"P Hollsberg","year":"2003","unstructured":"Hollsberg P et al (2003) Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol 132:137\u2013143","journal-title":"Clin Exp Immunol"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/brain\/awh453","volume":"128","author":"T Ishizu","year":"2005","unstructured":"Ishizu T et al (2005) Intrathecal activation of the IL-17\/IL-8 axis in opticospinal multiple sclerosis. Brain 128:988\u20131002","journal-title":"Brain"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1212\/01.wnl.0000256822.01222.bd","volume":"68","author":"S Jarius","year":"2007","unstructured":"Jarius S et al (2007) NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68:1076\u20131077","journal-title":"Neurology"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0002-9343(48)90389-1","volume":"4","author":"EA Kabat","year":"1948","unstructured":"Kabat EA et al (1948) Quantitative estimation of the albumin and gamma-globulin in normal and pathological cerebrospinal fluid by immunochemical methods. Am J Med 4:653\u2013662","journal-title":"Am J Med"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1212\/WNL.58.1.143","volume":"58","author":"M Keegan","year":"2002","unstructured":"Keegan M et al (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58:143\u2013146","journal-title":"Neurology"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","volume":"366","author":"M Keegan","year":"2005","unstructured":"Keegan M et al (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579\u2013582","journal-title":"Lancet"},{"key":"16_CR38","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1471-4159.1990.tb04173.x","volume":"55","author":"N Kerlero de Rosbo","year":"1990","unstructured":"Kerlero de Rosbo N et al (1990) Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin\/oligodendrocyte glycoprotein. J Neurochem 55:583\u2013587","journal-title":"J Neurochem"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1084\/jem.20041674","volume":"201","author":"M Krumbholz","year":"2005","unstructured":"Krumbholz M et al (2005) BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 201:195\u2013200","journal-title":"J Exp Med"},{"key":"16_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/brain\/awh680","volume":"129","author":"M Krumbholz","year":"2006","unstructured":"Krumbholz M et al (2006) Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129:200\u2013211","journal-title":"Brain"},{"issue":"7","key":"16_CR41","doi-asserted-by":"publisher","first-page":"e2559","DOI":"10.1371\/journal.pone.0002559","volume":"3","author":"B Kuenz","year":"2008","unstructured":"Kuenz B et al (2008) Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PloSONE 3(7):e2559","journal-title":". PloSONE"},{"key":"16_CR42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00415-006-0299-4","volume":"254","author":"J Kuhle","year":"2007a","unstructured":"Kuhle J et al (2007a) Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF. J Neurol 254:160\u2013168","journal-title":"J Neurol"},{"key":"16_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1056\/NEJMoa063602","volume":"356","author":"J Kuhle","year":"2007","unstructured":"Kuhle J et al (2007b) Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 356:371\u2013378","journal-title":"N Engl J Med"},{"key":"16_CR44","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1073\/pnas.0510672103","volume":"103","author":"PH Lalive","year":"2006","unstructured":"Lalive PH et al (2006) Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc Natl Acad Sci U S A 103:2280\u20132285","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR45","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"key":"16_CR46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA et al (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473\u2013477","journal-title":"J Exp Med"},{"key":"16_CR47","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","volume":"293","author":"LI Levin","year":"2005","unstructured":"Levin LI et al (2005) Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293:2496\u20132500","journal-title":"JAMA"},{"key":"16_CR48","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1191\/1352458505ms1187sr","volume":"11","author":"ET Lim","year":"2005","unstructured":"Lim ET et al (2005) Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis. Mult Scler 11:492\u2013494","journal-title":"Mult Scler"},{"issue":"Pt 11","key":"16_CR49","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/brain\/122.11.2089","volume":"122","author":"RB Lindert","year":"1999","unstructured":"Lindert RB et al (1999) Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain 122(Pt 11):2089\u20132100","journal-title":"Brain"},{"key":"16_CR50","first-page":"443","volume":"130","author":"C Linington","year":"1988","unstructured":"Linington C et al (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin\/oligodendrocyte glycoprotein. Am J Pathol 130:443\u2013454","journal-title":"Am J Pathol"},{"key":"16_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","volume":"180","author":"H Link","year":"2006","unstructured":"Link H, Huang YM (2006) Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 180:17\u201328","journal-title":"J Neuroimmunol"},{"key":"16_CR52","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1750-3639.1996.tb00854.x","volume":"6","author":"CF Lucchinetti","year":"1996","unstructured":"Lucchinetti CF et al (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol 6:259\u2013274","journal-title":"Brain Pathol"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C et al (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"16_CR54","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF et al (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125:1450\u20131461","journal-title":"Brain"},{"key":"16_CR55","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awl067","volume":"129","author":"JD Lunemann","year":"2006","unstructured":"Lunemann JD et al (2006) Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 129:1493\u20131506","journal-title":"Brain"},{"key":"16_CR56","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1084\/jem.20021294","volume":"197","author":"SA Luther","year":"2003","unstructured":"Luther SA et al (2003) Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development. J Exp Med 197:1191\u20131198","journal-title":"J Exp Med"},{"key":"16_CR57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","volume":"12","author":"IC MacLennan","year":"1994","unstructured":"MacLennan IC (1994) Germinal centers. Annu Rev Immunol 12:117\u2013139","journal-title":"Annu Rev Immunol"},{"key":"16_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jneuroim.2003.10.056","volume":"148","author":"R Magliozzi","year":"2004","unstructured":"Magliozzi R et al (2004) Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 148:11\u201323","journal-title":"J Neuroimmunol"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi R et al (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130:1089\u20131104","journal-title":"Brain"},{"key":"16_CR60","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0952-7915(02)00356-4","volume":"14","author":"RA Manz","year":"2002","unstructured":"Manz RA et al (2002) Humoral immunity and long-lived plasma cells. Curr Opin Immunol 14:517\u2013521","journal-title":"Curr Opin Immunol"},{"key":"16_CR61","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.immunol.23.021704.115723","volume":"23","author":"RA Manz","year":"2005","unstructured":"Manz RA et al (2005) Maintenance of serum antibody levels. Annu Rev Immunol 23:367\u2013386","journal-title":"Annu Rev Immunol"},{"key":"16_CR62","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/1352458507084595","volume":"14","author":"R Marignier","year":"2008","unstructured":"Marignier R et al (2008) NMO-IgG and Devic\u2019s neuromyelitis optica: a French experience. Mult Scler 14:440\u2013445","journal-title":"Mult Scler"},{"key":"16_CR63","doi-asserted-by":"publisher","first-page":"13992","DOI":"10.1073\/pnas.0504979102","volume":"102","author":"CB Marta","year":"2005","unstructured":"Marta CB et al (2005) Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci U S A 102:13992\u201313997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR64","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/brain\/awm027","volume":"130","author":"T Matsuoka","year":"2007","unstructured":"Matsuoka T et al (2007) Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130:1206\u20131223","journal-title":"Brain"},{"key":"16_CR65","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121\u2013127","journal-title":"Ann Neurol"},{"key":"16_CR66","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/brain\/awm047","volume":"130","author":"T Misu","year":"2007","unstructured":"Misu T et al (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130:1224\u20131234","journal-title":"Brain"},{"key":"16_CR67","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1365-2362.2005.01518.x","volume":"35","author":"A Moldenhauer","year":"2005","unstructured":"Moldenhauer A et al (2005) Immunoadsorption patients with multiple sclerosis: an open-label pilot study. Eur J Clin Invest 35:523\u2013530","journal-title":"Eur J Clin Invest"},{"key":"16_CR68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm1488","volume":"13","author":"KC O\u2019Connor","year":"2007","unstructured":"O\u2019Connor KC et al (2007) Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 13:211\u2013217","journal-title":"Nat Med"},{"key":"16_CR69","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ana.410430214","volume":"43","author":"GP Owens","year":"1998","unstructured":"Owens GP et al (1998) Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol 43:236\u2013243","journal-title":"Ann Neurol"},{"key":"16_CR70","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.4049\/jimmunol.171.5.2725","volume":"171","author":"GP Owens","year":"2003","unstructured":"Owens GP et al (2003) Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol 171:2725\u20132733","journal-title":"J Immunol"},{"key":"16_CR71","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1371\/journal.pmed.0040133","volume":"4","author":"F Paul","year":"2007","unstructured":"Paul F et al (2007) Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med 4:e133","journal-title":"PLoS Med"},{"key":"16_CR72","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1056\/NEJMc062467","volume":"356","author":"R Pelayo","year":"2007","unstructured":"Pelayo R et al (2007) Antimyelin antibodies with no progression to multiple sclerosis. N Engl J Med 356:426\u2013428","journal-title":"N Engl J Med"},{"key":"16_CR73","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/01.wnl.0000247665.94088.8d","volume":"67","author":"D Pohl","year":"2006","unstructured":"Pohl D et al (2006) High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 67:2063\u20132065","journal-title":"Neurology"},{"key":"16_CR74","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/jnnp.2005.077784","volume":"77","author":"S Rauer","year":"2006","unstructured":"Rauer S et al (2006) Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event. J Neurol Neurosurg Psych 77:739\u2013742","journal-title":"J Neurol Neurosurg Psych"},{"key":"16_CR75","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","volume":"83","author":"ME Reff","year":"1994","unstructured":"Reff ME et al (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435\u2013445","journal-title":"Blood"},{"key":"16_CR76","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/135245859800400304","volume":"4","author":"H Reiber","year":"1998","unstructured":"Reiber H (1998) Cerebrospinal fluid\u2013physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 4:99\u2013107","journal-title":"Mult Scler"},{"key":"16_CR77","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jneuroim.2006.06.028","volume":"180","author":"M Reindl","year":"2006","unstructured":"Reindl M et al (2006) Antibodies as biological markers for pathophysiological processes in MS. J Neuroimmunol 180:50\u201362","journal-title":"J Neuroimmunol"},{"key":"16_CR78","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF et al (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130:1194\u20131205","journal-title":"Brain"},{"key":"16_CR79","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","volume":"14","author":"B Serafini","year":"2004","unstructured":"Serafini B et al (2004) Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14:164\u2013174","journal-title":"Brain Pathol"},{"key":"16_CR80","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B et al (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204:2899\u20132912","journal-title":"J Exp Med"},{"key":"16_CR81","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nri1572","volume":"5","author":"M Shapiro-Shelef","year":"2005","unstructured":"Shapiro-Shelef M, Calame K (2005) Regulation of plasma-cell development. Nat Rev Immunol 5:230\u2013242","journal-title":"Nat Rev Immunol"},{"issue":"Pt 1A","key":"16_CR82","first-page":"181","volume":"114","author":"MK Sharief","year":"1991","unstructured":"Sharief MK, Thompson EJ (1991) Intrathecal immunoglobulin M synthesis in multiple sclerosis. Relationship with clinical and cerebrospinal fluid parameters. Brain 114(Pt 1A):181\u2013195","journal-title":"Brain"},{"key":"16_CR83","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0022-510X(90)90126-8","volume":"96","author":"MK Sharief","year":"1990","unstructured":"Sharief MK et al (1990) Intrathecal synthesis of IgM in neurological diseases: a comparison between detection of oligoclonal bands and quantitative estimation. J Neurol Sci 96:131\u2013142","journal-title":"J Neurol Sci"},{"key":"16_CR84","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/ana.410430409","volume":"43","author":"MK Storch","year":"1998","unstructured":"Storch MK et al (1998) Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann Neurol 43:465\u2013471","journal-title":"Ann Neurol"},{"key":"16_CR85","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/brain\/awm062","volume":"130","author":"T Takahashi","year":"2007","unstructured":"Takahashi T et al (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130:1235\u20131243","journal-title":"Brain"},{"key":"16_CR86","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.20820","volume":"59","author":"EL Thacker","year":"2006","unstructured":"Thacker EL et al (2006) Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 59:499\u2013503","journal-title":"Ann Neurol"},{"key":"16_CR87","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1177\/1352458507077622","volume":"13","author":"V Tomassini","year":"2007","unstructured":"Tomassini V et al (2007) Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult Scler 13:1086\u20131094","journal-title":"Mult Scler"},{"key":"16_CR88","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.it.2005.02.009","volume":"26","author":"A Uccelli","year":"2005","unstructured":"Uccelli A et al (2005) Unveiling the enigma of the CNS as a B-cell fostering environment. Trends Immunol 26:254\u2013259","journal-title":"Trends Immunol"},{"key":"16_CR89","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1212\/WNL.59.4.555","volume":"59","author":"LM Villar","year":"2002","unstructured":"Villar LM et al (2002) Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS. Neurology 59:555\u2013559","journal-title":"Neurology"},{"key":"16_CR90","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ana.10441","volume":"53","author":"LM Villar","year":"2003","unstructured":"Villar LM et al (2003) Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis. Ann Neurol 53:222\u2013226","journal-title":"Ann Neurol"},{"key":"16_CR91","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1212\/WNL.55.2.178","volume":"55","author":"K Wandinger","year":"2000","unstructured":"Wandinger K et al (2000) Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 55:178\u2013184","journal-title":"Neurology"},{"key":"16_CR92","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0165-5728(96)00235-4","volume":"75","author":"LY Wang","year":"1997","unstructured":"Wang LY, Fujinami RS (1997) Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol 75:75\u201383","journal-title":"J Neuroimmunol"},{"key":"16_CR93","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1212\/01.wnl.0000316195.52001.e1","volume":"71","author":"H Wang","year":"2008","unstructured":"Wang H et al (2008) Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology 71:1142\u20131146","journal-title":"Neurology"},{"key":"16_CR94","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","volume":"46","author":"BG Weinshenker","year":"1999","unstructured":"Weinshenker BG et al (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878\u2013886","journal-title":"Ann Neurol"},{"key":"16_CR95","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1155\/2006\/586306","volume":"22","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker BG et al (2006a) NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers 22:197\u2013206","journal-title":"Dis Markers"},{"key":"16_CR96","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.20770","volume":"59","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker BG et al (2006b) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566\u2013569","journal-title":"Ann Neurol"},{"key":"16_CR97","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM et al (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53:1107\u20131114","journal-title":"Neurology"},{"key":"16_CR98","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485\u20131489","journal-title":"Neurology"},{"key":"16_CR99","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jneuroim.2007.10.009","volume":"192","author":"KM Winges","year":"2007","unstructured":"Winges KM et al (2007) Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts. J Neuroimmunol 192:226\u2013234","journal-title":"J Neuroimmunol"},{"key":"16_CR100","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1172\/JCI119622","volume":"100","author":"KW Wucherpfennig","year":"1997","unstructured":"Wucherpfennig KW et al (1997) Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. J Clin Invest 100:1114\u20131122","journal-title":"J Clin Invest"},{"key":"16_CR101","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.4049\/jimmunol.168.10.5117","volume":"168","author":"P Yu","year":"2002","unstructured":"Yu P et al (2002) B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion. J Immunol 168:5117\u20135123","journal-title":"J Immunol"},{"key":"16_CR102","doi-asserted-by":"publisher","first-page":"19057","DOI":"10.1073\/pnas.0607242103","volume":"103","author":"D Zhou","year":"2006","unstructured":"Zhou D et al (2006) Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci U S A 103:19057\u201319062","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Results and Problems in Cell Differentiation","Molecular Basis of Multiple Sclerosis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/400_2008_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T01:35:56Z","timestamp":1684978556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/400_2008_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783642141522","9783642141539"],"references-count":102,"URL":"https:\/\/doi.org\/10.1007\/400_2008_16","relation":{},"ISSN":["0080-1844","1861-0412"],"issn-type":[{"type":"print","value":"0080-1844"},{"type":"electronic","value":"1861-0412"}],"subject":[],"published":{"date-parts":[[2009]]}}}